Clinical, laboratory and molecular-genetic markers of the progression of non-alcoholic fatty liver disease (literature review and own data)
A.A. ХamrayevTashkent medical Academy, Bukhara state medical institute. Tashkent, Bukhara, UzbekistanD.H. YuldashevaTashkent medical Academy, Bukhara state medical institute. Tashkent, Bukhara, Uzbekistan
ABI
Annotatsiya
Non-alcoholic fatty liver disease (NAFLD) is one of the most common diseases in hepatology. First of all, this is associated with a high risk of progression of NAFLD with the development of non-alcoholic steatohepatitis (NASH), liver failure, and hepatocellular carcinoma. Epidemiological and genetic studies have shown the relationship between the morphological stage of NAFLD and hereditary factors. The article provides a review of the literature on the cytokines, MBOAT7 and GCKR genes. Also, a variant of the MBOAT7 and GCKR gene is associated with a high risk of fibrosis in patients with NAFLD and elevated serum triglyceride levels.
Hali tarjima qilinmagan
Mavzular
Identifikatorlar
Iqtiboslar va manbalar
0 ta iqtibos21 ta foydalanilgan manba
Koʻrsatkichlar — AkademScholar · Tez orada